BAFF/APRIL heterotrimer: A core target for B-cell survival regulation and autoimmune disease therapy

Author: Senior Product Manager of UA Views：10

This article systematically elucidates the molecular characteristics and biological functions of B-cell activating factor (BAFF) and proliferation-inducing ligand (APRIL), focusing on their roles as members of the TNF ligand family in regulating B-cell survival, proliferation, and differentiation through three receptors (BAFFR, TACI, BCMA). It analyzes the unique structure and functional significance of BAFF/APRIL heterotrimers and explores their pathological relevance in autoimmune diseases such as systemic lupus erythematosus.

Recent Advances
Product Information

Recent Advances

BAFF/APRIL Heterotrimer: A Core Target for B Cell Survival Regulation and Autoimmune Disease Treatment

Summary
This article focuses on the molecular characteristics and biological functions of B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL), systematically elaborating their roles as members of the TNF ligand family in regulating B cell survival, proliferation, and differentiation through three receptors (BAFFR, TACI, BCMA). It analyzes the unique structure and functional significance of the BAFF/APRIL heterotrimer and explores its pathological relevance in autoimmune diseases such as systemic lupus erythematosus.

I. Molecular Characteristics and Family Classification of BAFF and APRIL

B cell-activating factor (BAFF), also known as TNFSF13B or CD257, is a critical B cell survival factor belonging to the tumor necrosis factor (TNF) ligand family. BAFF exists in both soluble and membrane-bound forms. A proliferation-inducing ligand (APRIL), also known as TNFSF13, is the closest relative of BAFF, sharing approximately 30% amino acid sequence homology. Both BAFF and APRIL function as homotrimers, but they can also assemble into heterotrimers through non-covalent bonds—comprising two BAFF subunits and one APRIL subunit or one BAFF subunit and two APRIL subunits—exhibiting unique receptor-binding profiles and functional characteristics.

BAFF is expressed on various cell types, including monocytes, dendritic cells, and bone marrow stromal cells. APRIL is primarily produced by macrophages, dendritic cells, and T cells. Both play synergistic and complementary regulatory roles in the immune system.

II. BAFF/APRIL Receptor System and Signal Transduction Mechanisms

BAFF exerts its biological functions by binding to three receptors: BAFFR (TNFRSF13C), TACI (TNFRSF13B), and BCMA (TNFRSF17). These receptors are members of the TNF receptor superfamily and exhibit differential expression patterns and functions at various stages of B cell development.

BAFFR is the primary receptor for BAFF, widely expressed from transitional B cells to mature and memory B cells, playing a central role in the BAFF system. Activation of BAFFR signaling primarily drives B cell survival and maturation, and its absence leads to the loss of over 90% of mature B cells. TACI exhibits more complex regulatory functions, providing both positive signals for B cell activation and negative regulation of excessive B cell activation. BCMA mainly supports the survival of long-lived plasma cells in the bone marrow, playing a key role in terminally differentiated plasma cells. APRIL primarily binds to TACI and BCMA, serving as a core regulator in plasma cell survival and antibody secretion.

III. Pathological Significance of BAFF/APRIL in Autoimmune Diseases

BAFF is implicated in the pathogenesis of many human autoimmune diseases. Elevated serum BAFF levels have been detected in patients with systemic lupus erythematosus, multiple sclerosis, IgA nephropathy, Sjögren's syndrome, and rheumatoid arthritis. Systemic lupus erythematosus is a chronic systemic autoimmune disease characterized by multi-system damage, with a complex pathogenesis involving the proliferation and activation of autoreactive T and B cells, production of various pathogenic autoantibodies, and abnormal cytokine secretion and receptor expression.

The mechanisms by which BAFF overexpression contributes to autoimmunity primarily involve two aspects: First, excess BAFF supports the survival of autoreactive B cells, enabling these cells to escape immune tolerance checkpoints, ultimately leading to autoantibody production and tissue damage. Second, BAFF also promotes T cell activation, proliferation, and differentiation, amplifying immune responses through positive feedback loops. The formation of BAFF/APRIL heterotrimers may further expand the ligand-receptor binding spectrum, enhancing the diversity of B cell activation signals and exerting synergistic effects in autoimmune pathology.

IV. Significance of BAFF/APRIL Heterotrimers in Therapeutic Target Development

The unique structure of BAFF/APRIL heterotrimers enables them to bind to receptors such as TACI and BCMA in ways distinct from homotrimers, thereby playing a broader role in the regulation of B cell and plasma cell survival. Therapeutic strategies targeting BAFF/APRIL heterotrimers may simultaneously block BAFF- and APRIL-mediated signaling pathways, offering more comprehensive intervention potential in autoimmune disease treatment.

V. Conclusion

As signaling molecules with unique structural and functional features within the TNF ligand family, BAFF/APRIL heterotrimers occupy a central position in B cell homeostasis maintenance and autoimmune disease pathogenesis through their precise regulation of B cell survival, proliferation, differentiation, and plasma cell function via three receptors. Their elevated expression in various autoimmune diseases, such as systemic lupus erythematosus, and their close association with disease activity make them highly promising therapeutic targets. Recombinant human BAFF&APRIL heterotrimer proteins provide critical tools for in-depth analysis of the fine regulatory mechanisms of this signaling network and related drug development.

In basic research and drug development targeting the BAFF/APRIL signaling pathway, high-quality recombinant proteins are essential tools for receptor binding analysis, neutralizing antibody evaluation, and signaling pathway studies. To meet these research needs, Uni offers BAFF&APRIL Heterotrimer His Tag Protein, Human, suitable for applications such as BAFF/APRIL binding activity analysis with BAFFR, TACI, and BCMA receptors, screening and evaluation of antibody drugs targeting the BAFF/APRIL pathway, and studies on B cell survival and differentiation mechanisms.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose Nanjing UA-Bio

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Youai is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UA Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next